Apart from one CpG with no change in methylation, the CpGs overlapping these DMRs showed a slight hypomethylation in CLL SF3B1mut patients with a maximum |log2(fold change)| = 0.3, within the ACOX3 gene (Table S2, column AI). This evidence concerns the gene ACOX3 and B-cell chronic lymphocytic leukemia.